Cargando…
International external quality assurance of JAK2 V617F quantification
External quality assurance (EQA) programs are vital to ensure high quality and standardized results in molecular diagnostics. It is important that EQA for quantitative analysis takes into account the variation in methodology. Results cannot be expected to be more accurate than limits of the technolo...
Autores principales: | Asp, Julia, Skov, Vibe, Bellosillo, Beatriz, Kristensen, Thomas, Lippert, Eric, Dicker, Frank, Schwarz, Jiri, Wojtaszewska, Marzena, Palmqvist, Lars, Akiki, Susanna, Aggerholm, Anni, Tolstrup Andersen, Morten, Girodon, François, Kjær, Lasse, Oppliger Leibundgut, Elisabeth, Pancrazzi, Alessandro, Vorland, Marta, Andrikovics, Hajnalka, Kralovics, Robert, Cassinat, Bruno, Coucelo, Margarida, Eftimov, Aleksandar, Haslam, Karl, Kusec, Rajko, Link-Lenczowska, Dorota, Lodé, Laurence, Matiakowska, Karolina, Naguib, Dina, Navaglia, Filippo, Novotny, Guy Wayne, Percy, Melanie J, Sudarikov, Andrey, Hermouet, Sylvie, Pallisgaard, Niels |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469832/ https://www.ncbi.nlm.nih.gov/pubmed/30535576 http://dx.doi.org/10.1007/s00277-018-3570-8 |
Ejemplares similares
-
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study
por: Jovanovic, J V, et al.
Publicado: (2013) -
Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives
por: Hasselbalch, Hans, et al.
Publicado: (2022) -
Ruxolitinib withdrawal due to the COVID-19
por: Lucijanic, Marko, et al.
Publicado: (2021) -
A comparison of qPCR and ddPCR used for quantification of the JAK2 V617F allele burden in Ph negative MPNs
por: Link-Lenczowska, Dorota, et al.
Publicado: (2018) -
Diffuse skin hyperpigmentation in CD30+ lymphoproliferation
por: Prka, Zeljko, et al.
Publicado: (2012)